glp 1 drugs and anesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general GLP-1 RA weight-loss drugs could
Description
The sales data, from market tracker PharmaTrac, marks an inflection point

2024:izae276

Those differences in manufacturing, ingredients and formulations are exactly what has some clinicians worried about their patients use of compounded GLP-1s

The medical director of the VCU Health Medical Weight Loss Program explains what these medications do to the body and why they might not be suited for everyone

New mechanisms for weight loss are continually being explored, offering new potential drug targets from cannabinoid receptor blockers, nucleotide-binding domain, leucine-richcontaining family, pyrin domaincontaining-3 (NLRP3) inhibitors, free fatty acid receptor 2 (FFA2) inhibitors and gene-editing RNA therapy
